Trial Outcomes & Findings for VItamin D Metabolism in SEnescent Cardiac Surgery Patients (NCT NCT01378221)
NCT ID: NCT01378221
Last Updated: 2014-01-30
Results Overview
Recruitment status
COMPLETED
Target enrollment
75 participants
Primary outcome timeframe
change from baseline within 1 month after cardiac surgery
Results posted on
2014-01-30
Participant Flow
Participant milestones
| Measure |
Group 1
cardiac surgery patients age 65 years and less
|
Group 2
cardiac surgery patients aged 75 years and over
|
|---|---|---|
|
Overall Study
STARTED
|
36
|
39
|
|
Overall Study
COMPLETED
|
29
|
30
|
|
Overall Study
NOT COMPLETED
|
7
|
9
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
VItamin D Metabolism in SEnescent Cardiac Surgery Patients
Baseline characteristics by cohort
| Measure |
Group 1
n=29 Participants
cardiac surgery patients age 65 years and less
|
Group 2
n=30 Participants
cardiac surgery patients aged 75 years and over
|
Total
n=59 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
Age
|
58.8 years
STANDARD_DEVIATION 5.92 • n=5 Participants
|
77.0 years
STANDARD_DEVIATION 4.38 • n=7 Participants
|
68.05 years
STANDARD_DEVIATION 5.14 • n=5 Participants
|
|
Sex: Female, Male
Female
|
2 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
11 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
27 Participants
n=5 Participants
|
21 Participants
n=7 Participants
|
48 Participants
n=5 Participants
|
|
Region of Enrollment
Germany
|
29 participants
n=5 Participants
|
30 participants
n=7 Participants
|
59 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: change from baseline within 1 month after cardiac surgeryOutcome measures
| Measure |
Group 1
n=29 Participants
cardiac surgery patients age 65 years and less
|
Group 2
n=30 Participants
cardiac surgery patients aged 75 years and over
|
|---|---|---|
|
Peri- and Postoperative Time Course of Circulating 1,25-dihydroxyvitamin D in the First Postoperative Month in Cardiac Surgery Patients
|
13 percentage
Standard Error 1.1
|
4.2 percentage
Standard Error 0.2
|
Adverse Events
Group 1
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Group 2
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Armin Zittermann
Heart and Diabetes Center North Rhine-Westphalia, Germany
Phone: +49 5731 97
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place